Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529–538. doi:10.1016/j.jhep.2006.05.013
   PubMed Web of Science ®Google Scholar
• Liu PH, Su CW, Hsu CY, et al. Solitary large hepatocellular carcinoma: staging and treatment strategy. PLoS One. 2016;11(5):e0155588. doi:10.1371/journal.pone.0155588
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi:10.1016/j.jhep.2021.11.018
   PubMed Web of Science ®Google Scholar
• Zhao HC, Wu RL, Liu FB, et al. A retrospective analysis of long term outcomes in patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma. HPB. 2016;18(11):943–949. doi:10.1016/j.hpb.2016.08.005
   PubMed Web of Science ®Google Scholar
• Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009;249(1):118–123. doi:10.1097/SLA.0b013e3181904988
   PubMed Web of Science ®Google Scholar
• Tsilimigras DI, Bagante F, Sahara K, et al. Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol. 2019;26(11):3693–3700. doi:10.1245/s10434-019-07580-9
   PubMed Web of Science ®Google Scholar
• Kim J, Kim JY, Lee JH, et al. Long-term outcomes of transarterial radioembolization for large single hepatocellular carcinoma: a comparison to resection. J Nucl Med. 2022;63(8):1215–1222. doi:10.2967/jnumed.121.263147
   PubMed Web of Science ®Google Scholar
• Hanazaki K, Kajikawa S, Shimozawa N, et al. Hepatic resection for large hepatocellular carcinoma. Am J Surg. 2001;181(4):347–353. doi:10.1016/S0002-9610(01)00584-0
   PubMed Web of Science ®Google Scholar
• Fang KC, Kao WY, Su CW, et al. The prognosis of single large hepatocellular carcinoma was distinct from Barcelona clinic liver cancer stage A or B: the role of albumin-bilirubin grade. Liver Cancer. 2018;7(4):335–358. doi:10.1159/000487407
   PubMed Web of Science ®Google Scholar
• Zhou L, Rui JA, Ye DX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surg. 2008;32(8):1748–1756. doi:10.1007/s00268-008-9615-8
   PubMed Web of Science ®Google Scholar
• Hermanek P, Wittekind C. The pathologist and the residual tumor (R) classification. Pathol Res Pract. 1994;190(2):115–123. doi:10.1016/S0344-0338(11)80700-4
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713
   PubMed Web of Science ®Google Scholar
• Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74. doi:10.1055/s-0030-1247133
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943. doi:10.1016/j.jhep.2011.12.001
   PubMed Web of Science ®Google Scholar
• Eguchi S, Takatsuki M, Hidaka M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg. 2010;34(5):1034–1038. doi:10.1007/s00268-010-0424-5
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–1092. doi:10.1002/lt.20472
   PubMed Web of Science ®Google Scholar
• Jung YK, Jung CH, Seo YS, et al. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A. J Gastroenterol Hepatol. 2016;31(2):467–474. doi:10.1111/jgh.13152
   PubMed Web of Science ®Google Scholar
• Huang J, Yang Y, Xia Y, et al. Prediction of patient survival following hepatic resection in early-stage hepatocellular carcinoma with indexed ratios of aspartate aminotransferase to platelets: a retrospective cohort study. Cancer Manag Res. 2021;13:1733–1746. doi:10.2147/CMAR.S284950
   PubMed Web of Science ®Google Scholar
• Wang JC, Hou JY, Chen JC, et al. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection. Eur J Cancer. 2021;155:85–96. doi:10.1016/j.ejca.2021.07.009
   PubMed Web of Science ®Google Scholar
• Wang H, Feng M, Jackson A, Ten Haken RK, Lawrence TS, Cao Y. Local and global function model of the liver. Int J Radiat Oncol Biol Phys. 2016;94(1):181–188. doi:10.1016/j.ijrobp.2015.09.044
   PubMed Web of Science ®Google Scholar
• Zhang JP, Wang HB, Lin YH, et al. Lactate dehydrogenase is an important prognostic indicator for hepatocellular carcinoma after partial hepatectomy. Transl Oncol. 2015;8(6):497–503. doi:10.1016/j.tranon.2015.11.006
   PubMed Web of Science ®Google Scholar
• Xia J, Song P, Sun Z, Sawakami T, Jia M, Wang Z. Advances of diagnostic and mechanistic studies of gamma-glutamyl transpeptidase in hepatocellular carcinoma. Drug Discov Ther. 2016;10(4):181–187. doi:10.5582/ddt.2016.01052
   PubMedGoogle Scholar
• Fukuda S, Itamoto T, Amano H, et al. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World J Surg. 2007;31(2):345–352. doi:10.1007/s00268-006-0513-7
   PubMed Web of Science ®Google Scholar
• Tanioka H, Omagari K, Kato Y, et al. Present status of hepatitis virus-associated hepatocellular carcinoma in Nagasaki Prefecture, Japan: a cross-sectional study of 1019 patients. J Infect Chemother. 2002;8(1):64–69. doi:10.1007/s101560200008
   PubMedGoogle Scholar
• Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462–503. doi:10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Kim SU, Jung KS, Lee S, et al. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int. 2014;34(7):1008–1017. doi:10.1111/liv.12475
   PubMed Web of Science ®Google Scholar
• Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249(4):617–623. doi:10.1097/SLA.0b013e31819ed22f
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–724. doi:10.1016/j.surg.2010.10.001
   PubMed Web of Science ®Google Scholar
• Gouw AS, Balabaud C, Kusano H, Todo S, Ichida T, Kojiro M. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl. 2011;17(Suppl 2):S72–S80. doi:10.1002/lt.22368
   PubMedGoogle Scholar
• Feng LH, Dong H, Lau WY, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143(2):293–303. doi:10.1007/s00432-016-2286-1
   PubMed Web of Science ®Google Scholar
• Rodriguez-Peralvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20(1):325–339. doi:10.1245/s10434-012-2513-1
   PubMed Web of Science ®Google Scholar
• Du M, Chen L, Zhao J, et al. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer. 2014;14:38. doi:10.1186/1471-2407-14-38
   PubMed Web of Science ®Google Scholar
• Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2010;102(5):462–468. doi:10.1002/jso.21631
   PubMed Web of Science ®Google Scholar
• Shen J, Wen T, Chen W, Lu C, Yan L, Yang J. Model predicting the microvascular invasion and satellite lesions of hepatocellular carcinoma after hepatectomy. ANZ J Surg. 2018;88(11):E761–E766. doi:10.1111/ans.14473
   PubMed Web of Science ®Google Scholar
• Li P, Huang W, Wang F, et al. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma. Biosci Rep. 2018;38(6). doi:10.1042/BSR20180464
   Google Scholar
• Ma X, Wei J, Gu D, et al. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol. 2019;29(7):3595–3605. doi:10.1007/s00330-018-5985-y
   PubMed Web of Science ®Google Scholar
• Andreana L, Burroughs AK. Treatment of early hepatocellular carcinoma: how to predict and prevent recurrence. Dig Liver Dis. 2010;42(Suppl 3):S249–S257. doi:10.1016/S1590-8658(10)60513-0
   PubMedGoogle Scholar
• Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002;81(4):195–202. doi:10.1002/jso.10178
   PubMed Web of Science ®Google Scholar
• An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ. Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology. 2015;276(2):433–443. doi:10.1148/radiol.15142394
   PubMed Web of Science ®Google Scholar
• Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol. 2007;14(10):2817–2823. doi:10.1245/s10434-007-9518-1
   PubMed Web of Science ®Google Scholar
• Plessier A, Codes L, Consigny Y, et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl. 2004;10(2 Suppl 1):S86–S90. doi:10.1002/lt.20039
   PubMedGoogle Scholar
• Hassan MM, Botrus G, Abdel-Wahab R, et al. Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2017;15(11):1791–1799. doi:10.1016/j.cgh.2017.05.036
   PubMed Web of Science ®Google Scholar
• Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–217. doi:10.1001/jamasurg.2018.4334
   PubMed Web of Science ®Google Scholar
• Lim C, Mise Y, Sakamoto Y, et al. Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma. World J Surg. 2014;38(11):2910–2918. doi:10.1007/s00268-014-2704-y
   PubMed Web of Science ®Google Scholar